ArticleArchives of dermatological research2025
Correction: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients.
Rok Seon Choung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.